Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureEmre Karayel, Nami Yeyin
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
In-fluence of time delay on the estimated lung shunt fraction on 99mTc-labeled MAA scintigraphy for 90Y microsphere treatment planning
10.1097/rlu.0000000000000241 · 2013
Unresolved referenced work
Kept as external metadata until matched
Dose-response and dose-toxicity relationships for glass 90Y radioembolization in patients with liver metastases from colorectal cancer
10.2967/jnumed.120.255745 · 2021
Feasibility of imaging 90Y microspheres at diagnostic activity levels for hepatic radioembolization treatment planning
10.1002/mp.13974 · 2020
90Y post-radioembolization clinical assessment with whole-body Biograph Vision Quadra PET/CT: image quality, tumor, liver and lung dosimetry
10.1007/s00259-024-06650-9 · 2024
Clinical impact of (99m)Tc-MAA SPECT/CT-based do-simetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres
10.1007/s00259-015-3157-8 · 2016
SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular can-cer
10.2967/jnumed.108.058347 · 2009
Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization
10.1007/s00259-011-2033-4 · 2012
Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distri-bution
10.1097/coc.0b013e318168ef65 · 2008
Lung dose calculation with SPECT/CT for 90 yittrium radioembolization of liver cancer
10.1016/j.ijrobp.2012.06.051 · 2013
Safety and efficacy of Y-90 mi-crosphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio
10.1186/1479-5876-5-15 · 2007
Dosimetry of Y-90 Microspheres utilizing Tc-99m SPECT and Y-90 PET
10.1053/j.semnuclmed.2019.01.005 · 2019
A review of 3D image-based dosimetry, technical considerations and emerging perspectives in 90Y microsphere therapy
10.17229/jdit.2015-0428-016 · 2015
Hepatopulmo-nary shunt ratio verification model for transarterial radioembolization
10.2174/0118744710284130240108053733 · 2024
Phantom validation of quantitative Y-90 PET/CT-based dosimetry in liver radioem-bolization
10.1186/s13550-017-0341-9 · 2017
Radioembolization of hepatocarcinoma with 90-Y glass microspheres: development of an individualized treat-ment planning strategy based on dosimetry and radiobiology
10.1007/s00259-015-3068-8 · 2015
Study on preparation of Y-90 microspheres in Da Lat Nuclear Reactor for application in treatment of primary and secondary liver cancers
10.13005/ojc/360414 · 2020
Diagnostic and prognostic val-ue of 99mTc-MAA SPECT/CT for treatment planning of 90Y-resin microsphere radioembolization for hepatocellular carcinoma: comparison with planar image
10.1038/s41598-021-82887-w · 2021
Unresolved referenced work
Kept as external metadata until matched
10.1371/journal.pone.0055742
10.1371/journal.pone.0055742
No additional external references are available.